CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

100 hedge funds and large institutions have $301M invested in Concert Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+8
Holders Change %
+8.7%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
34
Reduced
31
Closed
9
Calls
$332K
Puts
$25K
Net Calls
+$307K
Net Calls Change
+$68K

Top Buyers

1
CA
Corriente Advisors
Texas
$8.6M
2
BlackRock
BlackRock
New York
$27.9M
3
M&T Bank
M&T Bank
New York
$4.77M
4
PVI
Pura Vida Investments
New York
$3.71M
5
ACP
Acuta Capital Partners
California
$6.79M

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
$4.39M
2
Millennium Management
Millennium Management
New York
$11.3M
3
MAM
Martingale Asset Management
Massachusetts
$0
4
Renaissance Technologies
Renaissance Technologies
New York
$7.28M
5
Russell Investments Group
Russell Investments Group
United Kingdom
$1.54M
Name Holding Trade Value Shares
Change 		Shares
Change %
QI
101
QS Investors
New York
– -$389K -39,550 Closed
WG
102
Winton Group
United Kingdom
– -$309K -31,506 Closed
Squarepoint
103
Squarepoint
New York
– -$200K -20,393 Closed
AIM
104
Alambic Investment Management
California
– -$196K -19,934 Closed
Jane Street
105
Jane Street
New York
– -$163K -16,647 Closed
ACI
106
AMP Capital Investors
Australia
– -$131K -13,600 Closed
FHA
107
Flagship Harbor Advisors
Massachusetts
– -$39K -4,000 Closed
PCM
108
Prelude Capital Management
New York
– -$16K -1,666 Closed
1 2 3 4
5